Effectiveness of transdermal oestradiol and natural micronised progesterone for menopausal symptoms
- PMID: 30262631
- PMCID: PMC6146001
- DOI: 10.3399/bjgp18X699353
Effectiveness of transdermal oestradiol and natural micronised progesterone for menopausal symptoms
Comment on
-
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.JAMA. 2002 Jul 17;288(3):321-33. doi: 10.1001/jama.288.3.321. JAMA. 2002. PMID: 12117397 Clinical Trial.
References
-
- National Institute for Health and Care Excellence . Menopause: diagnosis and management NG23. London: NICE; 2015. - PubMed
-
- Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288(3):321–333. - PubMed
-
- Baber RJ, Panay N, Fenton A, IMS Writing Group 2016 IMS recommendations on women’s midlife health and menopause hormone therapy. Climacteric. 2016;19(2):109–150. - PubMed
-
- Hamoda H, Panay N, Arya R, Savvas M. The British Menopause Society & Women’s Health Concern 2016 recommendations on hormone replacement therapy in menopausal women. Post Reproductive Health. 2016;22(4):165–183. - PubMed
-
- L’Hermite M. HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT. Climacteric. 2013;16(Suppl 1):44–53. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources